内皮素-1与基质金属蛋白酶-9在喉癌中的表达与临床病理特征的相关性研究

林雁, 张京晶, 刘世喜, 等. 内皮素-1与基质金属蛋白酶-9在喉癌中的表达与临床病理特征的相关性研究[J]. 临床耳鼻咽喉头颈外科杂志, 2012, 26(6): 245-247,251. doi: 10.13201/j.issn.1001-1781.2012.06.009
引用本文: 林雁, 张京晶, 刘世喜, 等. 内皮素-1与基质金属蛋白酶-9在喉癌中的表达与临床病理特征的相关性研究[J]. 临床耳鼻咽喉头颈外科杂志, 2012, 26(6): 245-247,251. doi: 10.13201/j.issn.1001-1781.2012.06.009
LIN Yan, ZHANG Jingjing, LIU Shixi, et al. Significance expression and relationships with endothelin-1,matrix metalloproteinase-9 in the laryngeal Carcinoma[J]. J Clin Otorhinolaryngol Head Neck Surg, 2012, 26(6): 245-247,251. doi: 10.13201/j.issn.1001-1781.2012.06.009
Citation: LIN Yan, ZHANG Jingjing, LIU Shixi, et al. Significance expression and relationships with endothelin-1,matrix metalloproteinase-9 in the laryngeal Carcinoma[J]. J Clin Otorhinolaryngol Head Neck Surg, 2012, 26(6): 245-247,251. doi: 10.13201/j.issn.1001-1781.2012.06.009

内皮素-1与基质金属蛋白酶-9在喉癌中的表达与临床病理特征的相关性研究

详细信息
    通讯作者: 刘世喜,E-mail:liushixi_2008@126.com
  • 中图分类号: R739.65

Significance expression and relationships with endothelin-1,matrix metalloproteinase-9 in the laryngeal Carcinoma

More Information
  • 目的:探讨内皮素-1(ET-1)和基质金属蛋白酶-9(MMP-9)在喉癌中的表达情况及其与临床病理特征之间的相互关系。方法:采用免疫组织化学SP法检测58例喉癌、28例声带息肉及19例喉部正常黏膜组织中ET-1、MMP-9的表达。结果:喉癌组织中ET-1的表达率为81.03%(47/58),与声带息肉(57.14%)和喉部正常黏膜组织(57.89%)对比,差异有统计学意义(P<0.05)。MMP-9在喉癌中的表达率为72.41%(42/58),与声带息肉(50.00%)和喉部正常黏膜组织(47.37%)对比,差异有统计学差异(P<0.05)。ET-1、MMP-9的表达与喉癌的临床分期、浸润深度及有无淋巴结转移均有一定关系。结论:ET-1与MMP-9的高表达可能与喉癌的发生、发展关系密切,可为喉癌的靶向及个性化治疗策略提供一定的理论依据。
  • 加载中
  • [1]

    林雁,张京晶,刘世喜,等.内皮素A受体拮抗剂在人喉癌种植瘤的实验研究[J].华西医学,2009,24(10):2674-2676.

    [2]

    BHALLA A, HAQUE S, TAYLOR I,et al. Endothelin receptor antagonism and cancer[J].Eur J Clin Invest,2009,39:74-77.

    [3]

    陈志刚,王红静,周羽,等.内皮素-1及其受体在子宫内膜异位症中的表达及意义[J].四川大学学报(医学版),2009,40(3):422-425.

    [4]

    HERRMANN E,BOGEMANN M,BIERER S,et al.The role of the endothelin axis and microvessel density in bladder cancer-correlation with tumor angiogenesis and clinical prognosis [J].Oncol Rep,2007,18: 133-138.

    [5]

    DAS S,BANERJI A,FREI E,et al. Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells(MCF-7) to fibro- nectin in serum free medium[J].Life Sci,2008,82:467-476.

    [6]

    BECKER D P,BARTA T E,BEDELL L J,et al. Orally active MMP-1 sparing alpha- tetrahydropyranyl and alpha-piperidinyl sulfone matrix metallo- proteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease[J].J Med Chem,2010,53:6653-6680.

    [7]

    SILLANPAA S,NTTILA M,OUTILAINEN K, et al. Prognostic significance of matrix metalloproteinase-9(MMP-9)in epithelial ovarian cancer[J]. Gynecol oncol,2007,104:296-303.

    [8]

    SYMOWICZ J,ADLEY B,GLEASON K,et al. Engagement of collagen binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells[J].Cancer,2007,67: 2030-2039.

    [9]

    CAI K,YANG W,CAPO-CHICHI C,et al.Prominent expression of metallo proteinases in early stages of ovarian tumorigenesis[J].Mol Carcinog,2007,46:130-143.

    [10]

    TANGY,ZHU J,CHEN L,et al.Associations of matrix metalloproteinase-9 protein polymorphisms with lymph node metastasis but not invasion of gastric cancer[J].Clin Cancer Res,2008,14:2870-2877.

    [11]

    NAKAMURA T,KUWAI T,KIM J S,et al. Stromal metalloproteinase-9 is essential to angiogenesis and progressive growth of orthotopic human pancreatic cancer in parabiont nude mice[J].Neoplasia,2007,9: 979-986.

    [12]

    MAI H Q, ZENG Z Y, FENG K T. Therapeutic targeting of the endothelin a receptor in human nasopharyngeal carcinoma[J].Cancer Sci,2006, 97:1388-1395.

    [13]

    FISCHGRABE J,GOTTE M,SMOLLICH M,et al.Impact of VEGF on the expression of the endothelin axis in human breast cancer cell lines[J]. Onkolocie,2008,31:31-32.

    [14]

    ZHOU W Q,YIN H L,ZHANG Z Y, et al. Expression of VEGF in prostate cancer and its correlation with ET-1[J]. Zhong Hua Nan Ke Xue,2008,14: 987-992.

  • 加载中
计量
  • 文章访问数:  90
  • PDF下载数:  62
  • 施引文献:  0
出版历程
收稿日期:  2011-06-23

目录